UMM AI 
Built for Discovery. Engineered for Impact.
The Reality
The Complexity Life Science Organizations Are Managing
Drug development takes 10–15 years with high failure rates. AI and computational biology can accelerate discovery—but only for organizations with integrated data platforms.
The Data Challenge
Modern biology generates massive data that requires integrated platforms for AI-driven analysis.
The AI Opportunity
AI can accelerate drug discovery, but it requires unified data across research and clinical trials.
Regulatory compliance frameworks designed for paper-based processes now struggling with electronic submissions, data integrity validation, and audit trails for AI-driven decisions
Scientific computing infrastructure running on-premises hardware that can’t scale for computational biology workloads or provide the elasticity modern research demands
Research data fragmented across lab notebooks, instruments, and local drives with no unified platform for analyzing experiments, sharing results, or building on institutional knowledge.
Clinical trial data locked in study-specific databases that can’t be aggregated for cross-trial analysis, real-world evidence integration, or AI-driven patient cohort identification.
Molecular and genomic data at scales traditional databases can’t handle—requiring specialized infrastructure for storing, processing, and analyzing terabytes of sequencing and imaging data.
Our Point of View
Life Sciences Need Data Platforms, Not Just Tools
The organizations accelerating discovery aren’t those with the biggest budgets, but those with platforms that unify molecular, clinical, and real-world data for AI-driven insights.
Unified data platforms that integrate molecular biology, clinical trials, patient outcomes, and real-world evidence—not siloed systems where insights remain locked in individual studies.
Computational biology infrastructure with HPC, cloud-scale storage, and bioinformatics pipelines that process genomic, proteomic, and imaging data at research speed.
AI embedded in drug discovery workflows—from target identification and molecular design through patient stratification and clinical trial optimization.
Capability System
What We Build for Life Science Organizations
We architect and engineer the scientific data platforms, computational infrastructure, and AI systems that modern life science organizations run on—from target identification through clinical development to real-world evidence generation.
Research Data Platforms
Build unified platforms to capture and analyze research data across biology, chemistry, and experiments.
Includes
→ Scientific data platforms integrating instruments, notebooks, LIMS, and analysis tools with standardized metadata.
→ Cloud data lakes for molecular and genomic data enabling scalable bioinformatics analysis.
→Research collaboration platforms for sharing protocols, datasets, and analyses with version control and IP protection.
Computational Biology Infrastructure
Deploy cloud and HPC infrastructure for large-scale computational biology workloads.
Includes
→ Genomics pipelines for sequencing analysis with automation, quality control, and scalable compute.
→ Molecular modeling platforms for structure prediction, virtual screening, and simulations.
→ ML platforms for drug discovery enabling molecular data modeling and large-scale screening.
Clinical Data & Real-World Evidence
Integrate clinical trials, EHRs, and real-world data to enable patient stratification and outcome prediction.
Includes
→ Clinical data repositories enabling cross-trial analysis with standardized datasets.
→ Real-world evidence platforms integrating EHR, claims, and registry data with trial results.
→ Patient stratification models identifying biomarkers and predicting treatment response.
AI for Drug Discovery & Development
Deploy AI to accelerate target discovery, molecular design, patient selection, and clinical trials.
Includes
→ Target identification models analyzing genomic and proteomic data to prioritize druggable disease mechanisms.
→ AI-driven molecular design predicting compounds, synthesis routes, and safety profiles before synthesis.
→ Clinical trial optimization models predicting outcomes and improving enrollment and protocol design.
AI in Practice
Embed AI Into Discovery, Development, and Patient Outcomes
AI creates value in life sciences by accelerating target discovery, designing better molecules, predicting patient response, and optimizing clinical trials through unified data platforms.
Steps From AI Pilots to Real‑World Impact
Identify High-Impact R&D Workflows
Start where AI compresses timelines or reduces costs—such as target validation, virtual screening, patient stratification, adverse event prediction, or trial protocol optimization
Unify Research and Clinical Data
Build pipelines connecting molecular data, experimental results, clinical outcomes, and real-world evidence into platforms where AI can learn from the full drug development cycle
Deploy AI Into Research Workflows
Integrate models into discovery platforms, clinical systems, and trial management as intelligence that augments scientific judgment—not standalone predictions scientists don’t trus
Validate Against Outcomes
Measure AI predictions against experimental results, clinical endpoints, and patient outcomes—refining models based on what actually predicts success, not just statistical performance
Who We Serve
Who We Serve in Life Science
We partner with life science organizations where computational biology, data integration, and AI capabilities directly impact discovery speed, development costs, and patient outcomes.
Pharmaceutical Companies
Large pharma organizations—building platforms that integrate R&D data across therapeutic areas, enable computational drug discovery, connect clinical development with real-world evidence, and support regulatory submissions for global markets.
Biotech
Firms
Emerging biotech companies—deploying modern data infrastructure from inception, using cloud platforms for computational biology, implementing AI-first drug discovery, and building systems that scale from startup through commercialization.
Research Institutions
Academic medical centers and research institutes—creating platforms for collaborative science, managing large-scale sequencing and imaging data, integrating patient data for translational research, and enabling computational biology at scale.
Engineered for Science, Built for Regulatory Compliance
Clinical trial sponsors and diagnostic companies—building platforms for patient data integration, biomarker discovery, companion diagnostic development, and real-world evidence generation that connects molecular profiles to patient outcomes.
How We Work
Engineered for Science, Built for Regulatory Compliance
We combine life science expertise with computational platform engineering so solutions accelerate discovery while maintaining the data quality, traceability, and compliance regulatory agencies demand
Diagnose
Assess research data, infrastructure, and regulations to identify silos, compute gaps, and key acceleration opportunities.
Design
Design compliant platforms with cloud, bioinformatics pipelines, and AI frameworks for research workflows.
Deliver
Deploy incrementally in high-value areas, proving impact while ensuring compliant data management and validation.
The Future of Medicine Is
Computational
The organizations discovering tomorrow’s therapies are those that analyze more data, test more hypotheses, and learn faster from every experiment.
